Resting Aortic Valve Area at Normal Transaortic Flow Rate Reflects True Valve Area in Suspected Low-Gradient Severe Aortic Stenosis  by Chahal, Navtej S. et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 8 , N O . 1 0 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 5 . 0 4 . 0 2 1Resting Aortic Valve Area at Normal
Transaortic Flow Rate Reﬂects
True Valve Area in Suspected
Low-Gradient Severe Aortic Stenosis
Navtej S. Chahal, MBBS,*y Maria Drakopoulou, MD,* Ana M. Gonzalez-Gonzalez, MD,*
Ramasamy Manivarmane, MBBS,* Rajdeep Khattar, MBBS,*y Roxy Senior, MD*yzABSTRACTFro
Im
ser
con
MaOBJECTIVES This study sought to assess the diagnostic impact of stress echocardiography (SE) in patients with sus-
pected low-ﬂow, low-gradient aortic stenosis but normal resting transvalvular ﬂow rate.
BACKGROUND SE may help to distinguish between true severe aortic stenosis and pseudosevere aortic stenosis in
patients with low aortic valve area (AVA) and mean gradient. However, if rest ﬂow rate is normal, then SE may not confer
any additional diagnostic value, irrespective of resting left ventricular ejection fraction (LVEF) and indexed stroke
volume (SVi).
METHODS Sixty-seven patients with suspected low-ﬂow, low-gradient aortic stenosis who underwent SE were retro-
spectively studied. Following stratiﬁcation by rest LVEF, SVi, and ﬂow rate—using cutoffs of 50%, 35 ml/m2, and
200 ml/s, respectively—we tested for signiﬁcant changes in AVA during SE.
RESULTS Mean age was 77  9 years and 60% of patients were male. Mean values for rest variables were as follows:
AVA: 0.77  0.12 cm2; mean gradient: 27  7 mm Hg; ﬂow rate: 182  37 ml/s; SVi: 32  8 ml/m2; and LVEF: 45  15%.
During SE, signiﬁcant increases in AVA were observed regardless of resting LVEF and SVi state. In patients with rest ﬂow
rate$200ml/s, AVA did not increase signiﬁcantly during stress (rest AVA: 0.90 cm2 vs. stress AVA: 0.97 cm2; p¼0.11), and
positive predictive value for conﬁrming underlying true severe aortic stenosis was 84%. In adjusted analyses, rest ﬂow rate
was the only parameter associated with severe AS (odds ratio: 1.05, 95% conﬁdence interval: 1.0 to 1.1; p ¼ 0.002).
CONCLUSIONS Rest AVA measured under normal ﬂow rate conditions is likely to reﬂect the true severity of AS and
unlikely to change signiﬁcantly with SE. Flow normalization may only be required in patients with AVA <1 cm2 and mean
gradient <40 mm Hg when the rest ﬂow rate is <200 ml/s. (J Am Coll Cardiol Img 2015;8:1133–9)
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ABBR EV I A T I ON S
AND ACRONYMS
AS = aortic stenosis
AVA = aortic valve area
EF = ejection fraction
LFLGAS = low-ﬂow, low-
gradient aortic stenosis
LV = left ventricle
LVEF = left ventricular
ejection fraction
MG = mean gradient
PPV = positive predictive
value(s)
PSAS = pseudosevere aortic
stenosis
SE = stress echocardiography
SEP = systolic ejection period
SV = stroke volume
SVi = indexed stroke volume
TSAS = true severe aortic
stenosis
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1134physiology and/or reduced longitudinal
function (3). LFLGAS is typically suspected in
patients with a rest mean gradient (MG) <40
mm Hg, an AVA <1 cm2, an LVEF <50%, and/
or indexed stroke volume (SVi) <35 ml/m2
(4). To help differentiate between true
stenosis and pseudosevere disease, stress
echocardiography (SE) is performed to
normalize ﬂow, permitting AVA and trans-
aortic gradient to be remeasured at this
juncture (4–6).
However, if ﬂow is normal at rest, then
there may be little incremental value in per-
forming SE at all. Transvalvular ejection ﬂow,
or ﬂow rate, is the principal determinant of
both AVA and transvalvular gradient (1).
Rather than quantifying ejection ﬂow, much
of the research to-date, and consequently
clinical practice, has focused on surrogate
measures during rest and SE. Impaired LVEF
has been assumed to be a prerequisite to the
existence of a low-ﬂow state, and in routineclinical practice, an LVEF <40% to 50% remains the
principal “red ﬂag” for suspecting LFLGAS (4,7–9).
However, LVEF is poorly correlated with ﬂow state.
Cardiac output, stroke volume (SV), and ﬂow rate can
all be preserved in patients with reduced LVEF and a
dilated heart (10). Conversely, in patients with pre-
served LVEF, but advanced hypertrophic remodeling/
restrictive physiology, the consequent reduction in
SV has been used to deﬁne “low-ﬂow” in these pa-
tients (11).SEE PAGE 1140Flow rate can be simply measured during rest and
SE, by dividing the SV by the systolic ejection period
(SEP), with a normal rate considered to be 200 ml/s
(12). We hypothesized that transvalvular ﬂow rate is
superior to both SVi and LVEF in predicting the
impact of ﬂow correction on AVA in patients under-
going SE.
METHODS
STUDY POPULATION. From February 9, 2011 to
November 20, 2014, echocardiographic data were
retrospectively collected in 67 consecutive, symp-
tomatic patients who were all candidates for valve
intervention and who had been referred for SE to
further assess severity of LFLGAS, which was deﬁned
as an AVA <1 cm2, MG <40 mm Hg, and either
LVEF <50% or SVi <35 ml/m2. Of these, 18 patients
(27%) and 49 (73%) underwent exercise and dobut-
amine SE, respectively.Patients with other signiﬁcant valve disease,
prosthetic aortic valve, at least moderate aortic
regurgitation, or who developed signiﬁcant ischemia
during stress imaging were excluded from the study.
The study was approved by the local institutional
review board.
PROTOCOL. The protocol included an echocardio-
gram at baseline followed by stress imaging. Exercise
stress was performed either on a treadmill according to
Bruce protocol or bicycle ergometer using the World
Health Organization protocol. The test was inter-
rupted when the patient developed symptoms of AS or
when the patient reached the age-related maximum
heart rate. Doppler echocardiographic data were
collected at rest and peak- or post-exercise stress.
Dobutamine SE was performed according to a
standard protocol. Dobutamine was infused at an
initial dose of 5 mg/kg/min with 5-min increments up
to a maximum dosage of 20 mg/kg/min depending on
the severity of AS. Echocardiographic data were
obtained at rest and intermediate dobutamine dose
including pulse-wave Doppler-derived SV in the left
ventricular (LV) outﬂow tract, mean and peak
gradients by the simpliﬁed Bernoulli equation, AVA
by the continuity equation, mean transvalvular ﬂow
rate, and LVEF determined by the modiﬁed biplane
Simpson method. Flow rate was calculated by
dividing SV by the SEP (ms). Twenty-four patients
had suboptimal images for the assessment of LVEF
and ultrasound contrast enhancement was used
(Sonovue, Bracco, Milan, Italy). LV outﬂow tract
diameter was assumed to have remained constant
during the stress test protocol and was measured
only at rest.
Patients with stress AVA remaining at <1 cm2 and
stress MG increasing to $40 mm Hg were classiﬁed as
having TSAS (Figure 1A), with the remainder classiﬁed
as having PSAS (Figure 1B), according to conventional
criteria (4).
STATISTICS. Comparisons within groups were made
using paired Student t test for continuous variables
and McNemar test for categorical variables. To assess
the impact of SE, paired Student t test was used to
determine signiﬁcant changes in AVA within groups
and between groups using independent samples Stu-
dent t test—following stratiﬁcation by rest EF, SVi, and
ﬂow rate using cutoff values of 50%, 35 ml/m2, and
200 ml/s, respectively. Positive predictive values
(PPV) of normal rest ﬂow rate and normal rest SVi for
deﬁning TSAS were calculated using conventional
criteria as has already been mentioned; PPV was also
calculated when only an increase in stress MG to $40
mm Hg was evident, irrespective of stress AVA.
FIGURE 1 Assessment of Patients With Suspected LFLGAS Using SE
Echocardiographic images of (A) true-severe aortic stenosis (TSAS) and (B) pseudosevere aortic stenosis (PSAS): Rest (top) and low-dose dobutamine (bottom) Doppler
tracings of transaortic (left) and left ventricular outﬂow tract (LVOT) (right) ﬂow proﬁles. (A) At rest, mean gradient (MG) was 26 mm Hg and the aortic valve area (AVA)
was 0.74 cm2 with an impaired left ventricular ejection fraction (LVEF) (43%), a reduced indexed stroke volume (SVi) of 31 ml/m2 but a normal ﬂow rate of 209 ml/s.
During stress, there was a clinically signiﬁcant increase in MG to 45 mm Hg with no increase in AVA, conﬁrming presence of TSAS. Therefore, the resting AVA measured in
presence of a normal ﬂow rate was representative of the true severity of AS. (B) At rest, MG was 31 mm Hg and the AVA was 0.77 cm2 with preserved LVEF (57%), a
reduced SVi of 29 ml/m2, and a ﬂow rate of 171 ml/s. During stress, there was normalization of SVi (38 ml/m2) and ﬂow rate to 271 ml/s, with increase in AVA to 1.1 cm2 and
marginal rise of MG to 38 mm Hg. Accordingly, this patient was classiﬁed as having PSAS. bpm ¼ beats/min; CW ¼ continuous wave; LFLGAS ¼ low-ﬂow, low-gradient
aortic stenosis; PG ¼ peak gradient; PW ¼ pulsed wave; SE ¼ stress echocardiography; Vmax ¼ maximum velocity; Vmean ¼ mean velocity; VTI ¼ velocity time integral.
TABLE 1 Echocardiographic Parameters of AS and Systolic
Function at Rest and Stress
Rest Stress p Value
AVA, cm2 0.77  0.12 0.89  0.22 0.001
<1 67 (100) 49 (73) —
MG, mm Hg 27  7 37  11 <0.001
$40 0 (0) 27 (40) —
LVEF, % 45  15 52  16 <0.001
<50 37 (55) 22 (33) <0.001
SVi, ml/m2 32  8 39  15 0.002
<35 47 (70) 15 (22) 0.001
Flow rate, ml/s 182  37 239  73 <0.001
<200 48 (72) 14 (21) <0.001
Values are mean  SD or n (%). Dashes indicate the p values were not calculated.
AVA ¼ aortic valve area; LVEF ¼ left ventricular ejection fraction; MG ¼ mean
gradient; SVi ¼ indexed stroke volume.
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1135Multiple logistic regression was used to identify
independent, resting correlates of TSAS using a
stepwise method, adjusting for relevant echocardio-
graphic variables. Statistical signiﬁcance was deﬁned
as p < 0.05, and all statistical analyses were per-
formed using SPSS version 19 (IBM, Armonk, New
York).
RESULTS
Analysis was performed in 67 patients who met the
inclusion criteria and who successfully underwent
both rest and SE. The mean age of our cohort was 77 
9 years and 60% of the patients were male. Dobut-
amine stress was performed in the majority (73%).
There were no signiﬁcant differences in the de-
mographic or baseline echocardiographic parameters
between dobutamine and exercise stress groups,
except that the former group had signiﬁcantly more
patients with reduced LVEF at rest (41% vs. 59%;
p < 0.001) and SE (49% vs. 62%; p ¼ 0.03).
Table 1 summarizes echo parameters measured at
rest and stress. The average rest AVA was 0.77  0.12 cm2
and average MG was 27  7 mm Hg. At rest echocar-
diography, 55% had impaired LVEF (<50%), 70% had
reduced SVi (<35 ml/m2), and 72% had reduced ﬂow
rate (<200 ml/s). During stress, AVA remained <1 cm2in 73% and MG increased to $40 mm Hg in 40%. TSAS
(stress AVA <1 cm2 and stress MG $40 mm Hg) was
evident in 36% of patients (n ¼ 24).
The impact on AVA following stress and
augmentation of ﬂow/EF state within groups using
paired Student t test are shown in Table 2. Irre-
spective of LVEF or SVi at rest, signiﬁcant increases
in AVA were observed with stress. However, when
TABLE 2 Change in AVA During Stress, Stratiﬁed by Resting LVEF, SVi, and Flow
Rate State
n Rest AVA, cm2 Stress AVA, cm2 p Value
LVEF <50% 37 0.75  0.14 0.87  0.21 <0.001
LVEF $50% 30 0.79  0.10 0.93  0.23 0.007
SVi <35 ml/m2 47 0.74  0.12 0.86  0.23 <0.001
SVi $35 ml/m2 20 0.83  0.10 0.98  0.21 0.016
Q <200 ml/s 48 0.74  0.12 0.89  0.25 <0.001
Q $200 ml/s 19 0.85  0.09 0.89  0.12 0.19
Values are mean  SD.
Q ¼ ﬂow rate; other abbreviations as in Table 1.
TABLE 3 Predictive Value of Rest Flow Rate and SVi in Patients
With Rest AVA <1 cm2 and MG <40 mm Hg
PSAS TSAS PPV for TSAS, %
TSAS ¼ Stress AVA <1 cm2 and Stress MG $40 mm Hg*
Q <200 ml/s 40 8 17
Q $200 ml/s 3 16 84
SVi <35 ml/m2 35 12 26
SVi $35 ml/m2 9 11 55
TSAS ¼ Stress MG $40 mm Hg
Q <200 ml/s 39 9 19
Q $200 ml/s 1 18 95
SVi <35 ml/m2 34 13 28
SVi$35 ml/m2 6 14 70
Values are n unless otherwise indicated. *Conventional deﬁnition of TSAS.
PPV ¼ positive predictive value; PSAS ¼ pseudosevere aortic stenosis; TSAS ¼
true severe aortic stenosis; other abbreviations as in Tables 1 and 2.
TABLE 4 Adjusted Logistic Regression Analysis of Rest Function
Covariates Associated With TSAS
Coefﬁcient OR (95% CI) p Value
Resting LVEF, % 0.03 1.03 (0.98–1.10) 0.20
Resting SVi, ml/m2 0.001 1.00 (0.90–1.10) 0.98
Resting ﬂow rate, ml/s –0.05 1.05 (1.00–1.10) 0.002
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Tables 1 and 3.
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1136patients were stratiﬁed according to resting ﬂow
rate state, a signiﬁcant increase in AVA was only
evident among those with reduced ﬂow rate at rest;
in patients with normal ﬂow rate at rest, there was
no evidence of a signiﬁcant increase in AVA during
stress. Flow rate increased signiﬁcantly both in
low ﬂow group from 165 ml/s to 228 ml/s (p < 0.001)
and in normal ﬂow group from 226 ml/s to 268 ml/s
(p < 0.001). In patients with TSAS, a resting ﬂow rate
of 226  21 ml/s corresponded to an AVA of
0.85  0.1 cm2 and a MG of 31  4 mm Hg. Analysis
comparing change in AVA from rest to stress,
according to resting ﬂow/function between groups,
was performed using the Student t test for inde-
pendent samples. Again this showed signiﬁcant
change in AVA during stress between those patients
with rest ﬂow rate <200 ml/s compared with those
with normal rest ﬂow rate (change in AVA 0.16 cm2
vs. 0.04 cm2, respectively; p ¼ 0.025). However,
when stratiﬁed by LVEF or SVi, no signiﬁcant dif-
ferences in AVA change was observed (p ¼ 0.67 and
p ¼ 0.70, respectively), suggesting a similar magni-
tude of AVA increase was evident, irrespective of
resting LVEF or SVi.
Table 3 shows the predictive value of normal
resting ﬂow rate, compared to SVi, in conﬁrming the
presence of TSAS. Of 19 patients with normal rest
ﬂow rate, 16 (84%) met the conventional criteria of
TSAS during SE (Table 3, Figure 1A). Of the 3 patients
that were classiﬁed as not having TSAS according to
these criteria, 2 achieved MG $40 mm Hg during
stress, with their stress AVA remaining <1.1 cm2;
these patients could clinically be considered to have
severe AS. Thus, at a normal resting ﬂow rate, all but
1 patient demonstrated hemodynamic features of
severe AS, improving the PPV to 95% (Table 3).
However, patients with normal SVi at rest had a PPV
of 55% for deﬁning TSAS using conventional criteria
(Table 3), increasing to 70% when only an increase in
stress MG to $40 mm Hg was evident (Table 3).
Receiver-operating characteristic curve analysis ofrest ﬂow rate for predicting TSAS gave an area
under the curve of 0.84 and a ﬂow rate of 199 ml/s
for optimal accuracy in predicting TSAS, which can
be approximated to 200 ml/s for routine clinical
practice.
A logistic regression analysis of resting function
parameters (LVEF, SVi, and ﬂow rate) is presented in
Table 4, with only ﬂow rate being independently
associated with presence of TSAS (p ¼ 0.002). The
majority (73%) underwent dobutamine stress testing.
PPV for predicting severe AS in patients with normal
ﬂow rate were similar between the groups, 12 of 14
(86%) for dobutamine versus 4 of 5 (80%) for exer-
cise, although the number in the latter group is
small.
DISCUSSION
We have demonstrated that in patients with sus-
pected low-ﬂow, low-gradient TSAS, the AVA does
not change signiﬁcantly during SE if rest ﬂow rate is
normal, irrespective of rest LVEF or SVi. Moreover,
ﬂow rate was the only resting parameter of systolic
function independently associated with the presence
of TSAS. A normal rest ﬂow rate in suspected severe
AS carries an 84% PPV of deﬁning underlying TSAS
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1137(stress AVA <1 cm2 and MG >40 mm Hg) and this
increases to 95% if stress MG $40 mm Hg at an
AVA <1.1 cm2 is considered as severe AS, which is
clinically acceptable in symptomatic patients. By
contrast, PPV of normal SVi was 55% increasing to
70% when a stress MG $40 mm Hg alone was used to
deﬁne severe AS. Our data conﬁrmed that a low-ﬂow
state, deﬁned either by ﬂow rate or SVi, is a poor
discriminator of severity of AS.
The ﬁndings of this study suggest that in patients
with normal resting ﬂow rate, the corresponding AVA
is likely to be representative of the true hemodynamic
severity of the stenosis, and further ﬂow “correction”
is unlikely to yield further clinically measurable
changes and hence potentially obviating the need for
performing SE. However, in those with reduced ﬂow
rate at rest, stress testing is still indicated as a sig-
niﬁcant change in AVA; hence potential for PSAS still
exists.
We studied patients with both preserved and
impaired LVEF at rest with reduced AVA and low
mean transvalvular gradients. We observed that in
patients with normal range resting LVEF or SVi, a
signiﬁcant increase in AVA was still achievable with
stress. In multivariate analysis, rest ﬂow rate was the
only functional parameter independently associated
with TSAS.
Our clinical ﬁndings closely reproduce experi-
mental studies performed by Voelker et al. (12) who
observed ﬂow augmentation from low, initial resting
ﬂow rates (100 to 200 ml/s) increased the valve area
from 5% to 29% depending on underlying stenosis
severity. However at physiological ﬂow rates, ﬂow
augmentation (200 to 300 ml/s) did not alter valve
area in severe AS.
We have observed a high prevalence of PSAS in
our cohort, with several likely explanations. First,
although endorsed by recent American College of
Cardiology/American Heart Association guidelines
(4), there remains incongruity in the cutoffs for
gradient and AVA values for deﬁning severe AS. This
paper acknowledged that a MG $40 mm Hg corre-
sponds to a valve area of <0.8 cm2. One study found
that 30% of patients with severe AS by AVA had
nonsevere AS by MG (13). Indeed, in our patients with
TSAS, a rest AVA of 0.85 cm2 corresponded to MG of
31 mm Hg, whereas a mean AVA of <0.8 cm2 corre-
sponded to a stress MG of 40 mm Hg. Second,
vortices in the ascending aorta may result in under-
estimation of effective oriﬁce area using Doppler at
low ﬂow rates, potentially causing overdiagnosis of
PSAS. However, changes in AVA were found to be real
rather than due to artifact in an experimental model
using ﬁxed and compliant oriﬁces interrogated withparticle imaging velocimetry (14). Finally, there may
be patients without contractile reserve in this group
whose status of AS may be undetermined. This is
likely to be small because ﬂow rate increased signif-
icantly both in the low and normal rest ﬂow group
during stress.
IMPORTANCEOF DEFINING EJECTION FLOW, LIMITATIONS
OF STROKE VOLUME AND LVEF. There has been con-
siderable interest in deﬁning a “low-ﬂow state” in
patients with suspected severe AS but in whom the
recorded pressure drop across the valve is low. Low-
ﬂow states were thought to essentially exist only
in those patients with impairment of LVEF to at
least <40%, and the role of dobutamine challenge to
uncover ﬁxed valve stenosis and underestimated
transvalvular gradients was established in the liter-
ature (5). More recently, SV measured in the LV
outﬂow tract has been used to deﬁne ﬂow, and
particularly in the so-called paradoxical low-ﬂow
states, whereby the LVEF is preserved but cardiac
output is reduced due, usually, to restrictive physi-
ology/hypertrophic concentric remodeling.
Flow refers to the volume of blood passing
through a deﬁned region over a period of time. With
reference to AS states, ejection ﬂow is most germane
as this truly determines aortic valve opening as well
as transvalvular gradient (1). Ejection ﬂow, or ﬂow
rate, denotes the volume of blood that is ejected
during systole and is calculated by dividing SV by the
SEP. The importance of ﬂow rate has been acknowl-
edged recently when classifying the hemodynamic
response to dobutamine by calculating a projected
AVA to a standardized ﬂow rate (15). Although SV
does reﬂect a temporal component of ﬂow, namely a
heartbeat, and is a reasonable measure of systolic
function in most circumstances, it is less helpful as a
measure of ﬂow when assessing AS severity. The
duration of each heartbeat is determined by the
length of both systole and diastole. In severe AS,
maximum obstruction occurs later in systole, which
is best appreciated by the rounded shape of the
continuous-wave spectral Doppler velocity proﬁle.
Consequently, the ejection period is lengthened and
for the same heart rate, a patient with moderate
stenosis will have a higher ﬂow rate than a patient
with severe AS will, but they will have similar SV.
Thus, EF is not only determined by underlying sys-
tolic function, it also intrinsically reﬂects the severity
of outﬂow tract obstruction—being reduced in severe
stenosis due to prolongation of ejection time. In se-
vere AS, ﬂow rate can be signiﬁcantly diminished but
SV may remain in the normal range, potentially
confounding interpretation of discordant valve area
and gradient data.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The
entity of LFLGAS is well recognized and commonly
encountered in clinical practice. At present, SE is the
only diagnostic technique recommended to help
distinguish between true and pseudosevere forms of
AS. However, this may not be necessary if resting
ﬂow is normal, as the resting AVA is likely to be
representative of the underlying stenosis severity.
Therefore, accurate quantiﬁcation of rest ﬂow is of
paramount importance. Flow rate incorporates both
SV and ejection time and compared with SVi alone is
a better measure of ﬂow, particularly in patients
with AS.
TRANSLATIONAL OUTLOOK: Prospective, obser-
vational, and interventional studies are required to
assess whether in patients with LFLGAS resting ﬂow
rate alone is enough to exclude pseudosevere
stenosis.
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1138Flow rate is more closely correlated with cardiac
output, which will both vary with changes in heart
rate. However, SV will plateau and then diminish
with increasing heart rate (16); this phenomenon
should be taken into consideration when calcul-
ating SV increase during SE as a measure of contr-
actile reserve. Also, the optimal cutoff values for
low SVi also remain to be deﬁned and will vary ac-
cording to the technique used (volumetric vs.
Doppler) and demographic variables such as age, sex,
and ethnicity (17).
The limitation of LVEF as a surrogate of transaortic
ﬂow is evident in routine clinical practice. Flow rate
and SV can be normal despite signiﬁcant impairment
in LV systolic dysfunction; for example, in a patient
with a dilated LV, an end-diastolic volume of 200 ml
and end-systolic volume of 130 ml yields an SV of 70 ml,
a cardiac output of almost 5 l/min (assuming a heart rate
of 70 beats/min) and ﬂow rate of 200 ml/s (assuming an
ejection time of 350 ms but with an EF of only 35%).
Conversely, in patients with normal LVEF but concentric
LV remodeling and small volumes, both SVi and ﬂow
rate may be attenuated.
WHAT IS A NORMAL FLOW RATE? As mentioned
earlier, recognizing that ﬂow heterogeneity exists in
patients undergoing dobutamine SE and the impor-
tance of true ﬂow, the concept of a standardized ﬂow
rate of 250 ml/s was proposed, allowing projected
AVA to be determined (15). The value of 250 ml/s
chosen was an arbitrary one, based on data reported
from previous studies of patients with AS. However,
ﬂow at this rate would be associated with a supra-
normal cardiac output w6.1 l/min, at a heart rate of
70 beats/min and SEP of 350 ms. In our cohort of
patients with suspected severe AS, only 1 patient
had a rest ﬂow rate of >250 ml/s, who ultimately had
nonsevere stenosis with stress AVA increasing to >1 cm2.
We chose a cutoff for normal ﬂow rate of 200 ml/min
as used in experimental studies (12), which for a heart
rate of 70 beats/min and a SEP of 350 ms corresponds
to a normal cardiac output of 4.9 l/min. Moreover, a
receiver-operating characteristic curve analysis of
rest ﬂow rate for predicting TSAS gave a ﬂow rate of
199 ml/s for optimal accuracy in predicting TSAS,
which can be approximated to 200 ml/s for routine
clinical practice.
STUDY LIMITATIONS. This study has a retrospective
design, with relatively small number of patients.
Thus, further studies in larger and prospectively
determined cohorts are required with follow-up for
hard events to conﬁrm the utility of resting ﬂow rate
in helping to classify AS severity.CONCLUSIONS
Resting ﬂow rate, but not SVi or LVEF, can predict
changes in AVA during SE and is more closely corre-
lated with underlying AS severity. Resting AVA
measured under normal ﬂow rate conditions is likely
to reﬂect the true severity of AS—and is unlikely to
change signiﬁcantly with SE—thus the need for SE
maybe obviated.
CLINICAL IMPLICATIONS. We propose that ﬂow rate
should be measured routinely during rest echocardi-
ography in all patients with suspected LFLG severe
AS, which could obviate the need for SE in patients
with normal ﬂow rate. In our study, these patients
had a mean AVA of 0.85 cm2 and MG of 31 mm Hg at
rest at a mean ﬂow rate of 228 ml/s, and they can be
considered to have severe AS (13). Thus, carefully
measured parameters demonstrating an MG $30
mm Hg at a normal ﬂow rate, with AVA <1 cm2 should
provide reassurance that the underlying obstruction
is severe. This algorithm, however, would need to be
tested in a prospectively designed, interventional
study.
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